PharmaKB - Pharmaceutical Alpha Signals by Scientists for Investors.
Investors
Invest confidently with easy access to daily pharmaceutical trends, including financials, R&D milestones, and competitive intelligence.
|
What events impact a pharmaceutical? Where are investment opportunities? |
Analysts
Sharpen revenue predictions with data to support time series methods, such as revenues, trial success probabilities, and epidemiological data.
|
What will be the demand for a drug? What are a company's financial prospects? |
Quants
Predict stocks and revenues with quantitative data, such as competitive drugs, patent cliffs, trials, publications, and adverse events.
|
How will revenue change for a company? What events impact stock performance? |
Data Simplified
Drug, Disease, Clinical, Safety, Financial & Trend Reports
Comprehensive information covering entire drug lifecycles and disease markets within a single user-friendly interface. See a sample report.
Consolidated & Standardized Data
Semantic technology standardizes data for easy cross-referencing and integrations with AI Applications.
Real-Time Automated Data
Automated data streams from hundreds of sources, updated daily.
Pricing Simplified
Free for academia and commercial options starting at $99/month. See subscriptions.
Smart Data Saves Time™
NUMBER OF RESEARCHERS
RESEARCH TIME
YEARLY COST SAVINGS
Source: 'Cost of not having FAIR research data' by PwC EU Services
Frequently Asked Questions
- Where/how does PharmaKB get the data for its reports?
- What makes PharmaKB different from other drug databases?
- How many drugs are in the PharmaKB Database?
- Can we receive bulk discounting?
- Can I integrate my proprietary data with the public data collected by PharmaKB?
- Can I request additional drugs or information be added to the individual PharmaKB reports?
- Can I search across the PharmaKB database for specific companies, drugs, or disease information?
- What are some use cases for PharmaKB?